We are live on ! Find out more
LGM

Logos Global Management Portfolio holdings

AUM $2B
1-Year Est. Return 444.09%
This Fund
S&P 500
This Quarter Est. Return
+93.02%
1 Year Est. Return
+444.09%
3 Year Est. Return
+1,593.63%
5 Year Est. Return
+2,146.66%
10 Year Est. Return
–
AUM
$406M
AUM Growth
–
Cap. Flow
+$328M
Cap. Flow %
80.95%
Top 10 Hldgs %
56.89%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$24.5M
2
SAGE
Sage Therapeutics
SAGE
+$23.4M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$22.8M
4
ASND icon
Ascendis Pharma A/S
ASND
+$20M
5
AMRN
Amarin Corp
AMRN
+$18.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 81.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$32.7M 8.06%
+253,660
New +$24.5M
SRPT icon
2
Sarepta Therapeutics
SRPT
$1.7B
$29.2M 7.19%
+226,002
New +$22.8M
MRTX
3
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$27.1M 6.67%
+210,000
New +$20.3M
MRTX
4
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$25.8M 6.35%
+200,000
New +$19.3M
ASND icon
5
Ascendis Pharma A/S
ASND
$16.8B
$25M 6.17%
+179,898
New +$20M
AMRN
6
Amarin Corp
AMRN
$289M
$20.6M 5.09%
+48,128
New +$18.3M
APLS
7
DELISTED
Apellis Pharmaceuticals
APLS
$18M 4.43%
+587,108
New +$16.2M
BLUE
8
DELISTED
bluebird bio
BLUE
$17.9M 4.42%
+15,781
New +$17.2M
ZYME icon
9
Zymeworks
ZYME
$1.71B
$17.7M 4.36%
+389,153
New +$14.1M
MYOK
10
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$16.8M 4.15%
+231,009
New +$14M
ZGNX
11
DELISTED
Zogenix, Inc.
ZGNX
$15M 3.69%
+287,024
New +$13.1M
XLRN
12
DELISTED
Acceleron Pharma
XLRN
$14.2M 3.5%
+267,676
New +$12.2M
SAGE
13
DELISTED
Sage Therapeutics
SAGE
$13.7M 3.38%
+190,150
New +$23.4M
AXSM icon
14
Axsome Therapeutics
AXSM
$12.4B
$12.9M 3.18%
+124,937
New +$5.05M
RETA
15
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$11.4M 2.81%
+55,700
New +$10.2M
BHVN
16
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10.2M 2.51%
+187,242
New +$9.27M
BMY.RT
17
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$10M 2.47%
+3,322,816
New +$8.64M
QURE icon
18
uniQure
QURE
$2.68B
$9.92M 2.45%
+138,425
New +$7.6M
CCXI
19
DELISTED
ChemoCentryx, Inc.
CCXI
$7.37M 1.82%
+186,238
New +$3.27M
KDMN
20
DELISTED
Kadmon Holdings, Inc.
KDMN
$6.12M 1.51%
+1,350,351
New +$4.94M
IOVA icon
21
Iovance Biotherapeutics
IOVA
$2.26B
$6.11M 1.5%
+220,543
New +$5.02M
SWTX
22
DELISTED
SpringWorks Therapeutics
SWTX
$5.17M 1.28%
+134,397
New +$3.15M
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$357M
$5.08M 1.25%
+223,337
New +$3.73M
CNST
24
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$4.76M 1.17%
+101,050
New +$2.92M
MTEM
25
DELISTED
Molecular Templates, Inc.
MTEM
$4.75M 1.17%
+22,660
New +$3.26M
1
2

Similar funds

MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
LBC
Lowe Brockenbrough & Co Richmond, Virginia $2.01B AUM 22.05% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

Logos Global Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Logos Global Management, which disclosed 40 positions worth $406M. Its ten largest holdings account for 57% of the portfolio.

Its largest position is Mirati Therapeutics, Inc. Common Stock: 253,660 shares worth $32.7M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets.

  • Logos Global Management's largest Q4 2019 buy was Mirati Therapeutics, Inc. Common Stock: 253,660 shares worth $32.7M.
  • Logos Global Management's ten largest holdings make up 57% of its $406M portfolio in Q4 2019.
  • Logos Global Management disclosed 40 positions in Q4 2019, its first 13F filing on record.

Based on Logos Global Management's 13F filing for Q4 2019, filed 14 Feb 2020.